Dr. Gregory J Czarnota, PhD, MD
Claim this profileSunnybrook Health Sciences Centre
Studies Breast Cancer
Studies Head and Neck Cancers
8 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
Stage II
Stage I
Stage III
2Head And Neck Cancers
Stage III
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Gregory J Czarnota, PhD, MD is currently running
Focused Ultrasound Radiosensitization
for Melanoma
The objective of this study is to examine the safety profile and therapeutic efficacy of MRI-guided focused ultrasound microbubble therapy and radiotherapy in humans.
Recruiting1 award Phase 1
Ultrasound-Guided Chemotherapy
for Breast Cancer
The primary objective of this study is to assess the feasibility of randomizing breast cancer patients to quantitative ultrasound to guide adaptive Neoadjuvant Chemotherapy as compared to standard clinical monitoring and therapy. The Investigators have previously demonstrated that high-frequency ultrasound and spectroscopy, and recently conventional-frequency ultrasound and spectroscopy may be used to detect cell death in vitro, in situ and in vivo. The method can detect different forms of cell death and has been demonstrated to be sensitive to apoptotic, necrotic and mitotic cell death. By detecting cell death early in a treatment on the order of hours to days, rather than traditional anatomical assessments that take place weeks to months after the completion of therapy, ineffective therapies could be switched to more efficacious treatments or aggressive salvage therapy which has shown to already benefit patients. The overarching goal of this research is to transform the delivery of neoadjuvant chemotherapy using quantitative ultrasound (QUS), which is non-invasive, inexpensive and portable.
Recruiting1 award N/A8 criteria
More about Gregory J Czarnota, PhD, MD
Clinical Trial Related9 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Gregory J Czarnota, PhD, MD has experience with
- Ultrasound Imaging
- Spectroscopy
- Sonalleve Focused Ultrasound Device
- Definity
- MRI-guided Ultrasound Stimulated Microbubble Treatment
- LINAC Radiation Therapy Device
Breakdown of trials Gregory J Czarnota, PhD, MD has run
Breast Cancer
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory J Czarnota, PhD, MD specialize in?
Gregory J Czarnota, PhD, MD focuses on Breast Cancer and Head and Neck Cancers. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage I.
Is Gregory J Czarnota, PhD, MD currently recruiting for clinical trials?
Yes, Gregory J Czarnota, PhD, MD is currently recruiting for 3 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Gregory J Czarnota, PhD, MD has studied deeply?
Yes, Gregory J Czarnota, PhD, MD has studied treatments such as Ultrasound Imaging, Spectroscopy, Sonalleve Focused Ultrasound Device.
What is the best way to schedule an appointment with Gregory J Czarnota, PhD, MD?
Apply for one of the trials that Gregory J Czarnota, PhD, MD is conducting.
What is the office address of Gregory J Czarnota, PhD, MD?
The office of Gregory J Czarnota, PhD, MD is located at: Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5 Canada. This is the address for their practice at the Sunnybrook Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.